Angioplasty Balloon Catheters
Angioplasty balloon catheters are a sub-segment of the intracranial stenosis stents market. These catheters are used to dilate and open narrowed or blocked blood vessels in the brain. They are inserted into the stenotic artery and inflated to restore blood flow. The increasing prevalence of intracranial stenosis and the rising demand for minimally invasive procedures are driving the adoption of angioplasty balloon catheters. Additionally, the advancements in catheter technology, such as the development of drug-eluting balloon catheters, further contribute to their market growth.
Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation
Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation are some of the key players in the intracranial stenosis stents market. These companies focus on strategic partnerships, collaborations, and acquisitions to strengthen their market position. They also invest heavily in research and development activities to develop innovative and technologically advanced stents for the treatment of intracranial stenosis. The market players adopt various growth strategies to gain a competitive edge in the market and expand their product portfolio.